How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,002 results for

E/M Established Outpatient Visit

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies

time, alternative causes of anxiety such as mood or substance use disorders, physical illness or its treatment should be considered (Lampe, 2015; McEvoy et al., 2011). Anxiety disorders are associated with high levels of dis- tress, disability and service use (Slade et al., 2009b), yet only a minority of people with anxiety disorders get ade- quate treatment (Harris et al., 2015). Fewer than half seek treatment by visiting a health professional. Those who do, commonly attend primary care and only (...) management of anxiety disorders also involves consideration of issues for people in various age groups, sociocultural diversity, issues for indigenous cultures, and important comorbidities. First published in the Australian and New Zealand Journal of Psychiatry 2018, Vol. 52(12) 1109-1172.1118 ANZJP Articles Structured clinical interviews. There are four well-established diagnostic interviews that generate a reliable and valid diagnosis: • • Structured Clinical Interview for Axis 1 DSM-IV Disorders

2018 Royal Australian and New Zealand College of Psychiatrists

162. Home-Based Cardiac Rehabilitation: Scientific Statement

services (e.g., medications, outpatient care, inpatient care), 2 reports found no signi?cant difference in use between HBCR and CBCR (41,70), and 1 study reported fewer medical visits and hospitalizations with HBCR (53). Quality-adjusted life-years were reported in 2 studies, and both found no signi?cant difference in quality-adjusted life-years be- tweenHBCRandCBCR(41,70).OnestudyfromtheUnited Statesincludedlimitedcostdataandsuggestedthatcosts may be lower for HBCR compared with CBCR (35). Risk (...) are generally not covered by third-party payers in the United States. One exception is the MULTIFIT home-based pro- gram implemented at Kaiser Permanente Northern Cali- fornia (77). This nurse-based case management system starts during hospitalization for acute MI or revasculari- zation and is followed over the subsequent 6 months by up to 12 nurse-initiated telephone contacts, up to 4 outpatient visits with a nurse case manager, and computer-generated progress reports based on patient

2019 American College of Cardiology

163. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review

Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review A Campbell Systematic Review 2018:9 Education Coordinating Group Emily A. Hennessy, Emily E. Tanner-Smith, Andrew J. Finch, Nila Sathe, Shannon Kugley Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review Published: October 2018 Search executed: September 2018The (...) Campbell Library comprises: • Systematic reviews (titles, protocols and reviews) • Policies and Guidelines Series • Methods Series Go to the library to download these resources, at: www.campbellcollaboration.org/library/ Better evidence for a better world Colophon Title Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review Authors 1 Emily A. Hennessy 2 Emily E. Tanner-Smith 3 Andrew J. Finch 4 Nila Sathe 5 Shannon

2018 Campbell Collaboration

164. Assessment and Management of Patients at Risk for Suicide

Affairs Populations 8 C. Identifying Suicide Risk in VA and DoD Populations 9 III. About this Clinical Practice Guideline 10 A. Methods 11 a. Grading Recommendations 12 b. Reconciling 2013 Clinical Practice Guideline Recommendations 13 c. Peer Review Process 14 B. Summary of Patient Focus Group Methods and Findings 14 C. Conflicts of Interest 16 D. Scope of this Clinical Practice Guideline 16 E. Highlighted Features of this Clinical Practice Guideline 17 F. Patient-centered Care 17 G. Shared Decision (...) VA/DoD Clinical Practice Guideline for the Assessment and Management of Patients at Risk for Suicide May 2019 Page 4 of 142 C. Other Management Modalities 50 a. Population & Community-based Interventions 50 D. Knowledge Gaps and Recommended Research 54 a. Screening for Suicide Risk 54 b. Evaluation, Determining Level of Risk, and Relationship to Treatment 54 c. Risk and Protective Factors 54 d. Non-pharmacologic Interventions 55 e. Pharmacologic Interventions 55 f. Post-acute Care Approaches 56 g

2019 VA/DoD Clinical Practice Guidelines

165. Management of Stroke Rehabilitation

. About this Clinical Practice Guideline 7 A. Methods 7 a. Grading Recommendations 8 b. Reconciling 2010 Clinical Practice Guideline Recommendations 10 c. Peer Review Process 11 B. Summary of Patient Focus Group Methods and Findings 11 C. Conflicts of Interest 12 D. Scope of this Clinical Practice Guideline 13 E. Highlighted Features of this Clinical Practice Guideline 13 F. Patient-centered Care 13 G. Shared Decision Making 14 H. Co-occurring Conditions 14 I. Implementation 14 IV. Guideline Work (...) Group 15 V. Algorithm 17 A. Module A: Rehabilitation Disposition of the Inpatient with Stroke 18 B. Module B: Outpatient/Community-Based Rehabilitation 19 VI. Recommendations 23 A. Approach and Timing 27 B. Motor Therapy 30 a. Upper and Lower Limbs Rehabilitation 30 b. Technology-Assisted Physical Rehabilitation 37 c. Pharmacological Treatment in Motor Therapy 45 C. Dysphagia Therapy 48 D. Cognitive, Speech, and Sensory Therapy 55 a. Cognitive Therapy 55 b. Speech Therapy 56 c. Spatial Neglect

2019 VA/DoD Clinical Practice Guidelines

166. The economic evaluation of early intervention with Anti-Tumor Necrosis Factor-alpha treatments in pediatric Crohn's disease

Staff Physician, Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Canada Anne M. Griffiths, MD Staff Physician, Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Canada Shinya Ito, MD Head, Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, Canada Professor, Faculty of Medicine, The University of Toronto, Toronto, Canada Wendy J. Ungar, MSc, PhD Senior Scientist, Child Health Evaluative (...) vi 2.1 Overview of Methods and Study Design 27 2.2 The Pediatric Crohn’s Disease Cohort 29 2.2.1 The RISK-PROKIIDS Study Data 29 2.2.1.1 Inclusion Criteria 30 2.2.2 Data Extraction and Patient Characteristics from the RISK-PROKIIDS Study 32 2.2.2.1 Assigning Visit Dates 32 2.2.2.2 Determining Patient Health State 34 2.2.2.2.1 The Weighted Pediatric Crohn’s Disease Activity Index and the Physician Global Assessment 35 2.2.2.3 Treatment Determination 38 2.2.2.4 Extracting Patient Characteristics

2019 SickKids Reports

167. Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review

Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00008-I Prepared by: Minnesota Evidence-based Practice Center Minneapolis, MN Investigators: Howard A. Fink, M.D., M.P.H. Roderick MacDonald, M.S. Mary L. Forte, Ph.D., D.C. Christina E. Rosebush, M.P.H. Kristine E. Ensrud, M.D., M.P.H. John T. Schousboe, M.D., Ph.D. Victoria A. Nelson, M.Sc. Kristen Ullman, M.P.H. Mary Butler, Ph.D., M.B.A. Carin M. Olson, M.D. Brent C. Taylor, M.P.H., Ph.D. Michelle Brasure, Ph.D., M.S.P.H., M.L.I.S (...) website at www.effectivehealthcare.ahrq.gov. Search on the title of the report. Persons using assistive technology may not be able to fully access information in this report. For assistance contact epc@ahrq.hhs.gov. Suggested citation: Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, Nelson VA, Ullman K, Butler M, Olson CM, Taylor BC, Brasure M, Wilt TJ. Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review. Comparative Effectiveness

2019 Effective Health Care Program (AHRQ)

168. National Early Warning Score

and available resources.National Clinical Effectiveness Committee (NCEC) The National Clinical Effectiveness Committee (NCEC) was established as part of the Patient Safety First Initiative in September 2010. The NCECs mission is to provide a framework for national endorsement of clinical guidelines and audit to optimise patient and service user care. The NCEC has a remit to establish and implement processes for the prioritisation and quality assurance of clinical guidelines and clinical audit so (...) and clinical treatment. • Any outpatient/day service patients who attend acute hospitals for an invasive procedure or who receive sedation. • All patients attending an Acute Medical Unit/Acute Medical Assessment Unit/Medical Assessment Unit. The National Clinical Guideline applies to healthcare professionals, doctors, nurses, physiotherapists and other staff involved in the clinical care of patients and managers responsible for the development, implementation, review and audit of deteriorating patient

2019 National Clinical Guidelines (Ireland)

169. Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD

5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00013-I Prepared by: Mayo Clinic Evidence-based Practice Center Rochester, MN Investigators: Claudia C. Dobler, M.D., Ph.D. Allison S. Morrow, B.A. Magdoleen H. Farah, M.B.B.S. Bradley Beuschel, B.S.P.H. Abdul M. Majzoub, M.D. Michael E. Wilson, M.D. Bashar Hasan, M.D. Mohamed O. Seisa, M.D. Lubna Daraz, Ph.D. Larry J. Prokop, M.L.S. M. Hassan Murad, M.D., M.P.H. Zhen Wang, Ph.D. AHRQ Publication No. 19(20)-EHC024-EF October (...) questions about the optimal nutritional support for patients with ECOPD. 31, 32 Established treatments for ECOPD, such as antibiotics and systemic corticosteroids, may not be indicated in every single episode of an ECOPD. One uncertainty relates to the need for antibiotics in mild and moderately severe ECOPD, especially in an outpatient setting. 33 While antibiotics for treatment of severe ECOPD have been shown to be beneficial in some studies, the need for antibiotics in less severe forms of COPD

2019 Effective Health Care Program (AHRQ)

170. Brief psychological interventions for young people with common mental health conditions

. 2015;20(1):49-55. 34. Piet J, Hougaard, E., Hecksher, M. S. & Rosenberg, N. K. . A randomized pilot study of mindfulness- based cognitive therapy and group cognitive- behavioral therapy for young adults with social phobia. Scandinavian Journal of Psychology. 2010;51:403–410. 35. Walsh E, Eisenlohr-Moul T, Baer R. Brief mindfulness training reduces salivary IL-6 and TNF-alpha in young women with depressive symptomatology. J Consult Clin Psychol. 2016 Oct;84(10):887-97. 36. Baer RA. Mindfulness Training (...) as a Clinical Intervention: A Conceptual and Empirical Review. Clinical Psychology: Science and Practice. 2003;10(2):125-143. 37. Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010 Jun;68(6):539-44. 38. Fjorback LO, Arendt M, Ornbol E, Fink P, Walach H. Mindfulness-based stress reduction and mindfulness-based cognitive therapy: a systematic review

2019 Orygen, The National Centre of Excellence in Youth Mental Health

171. Surveillance, Diagnosis and Management of Clostridium Difficile Infection in Ireland

Surveillance, Diagnosis and Management of Clostridium Difficile Infection in Ireland Surveillance, Diagnosis and Management of Clostridium difficile Infection in Ireland National Clinical Guideline No. 3 June 2014National Clinical Effectiveness Committee (NCEC) The National Clinical Effectiveness Committee (NCEC) was established as part of the Patient Safety First Initiative in September 2010. The NCECs mission is to provide a framework for national endorsement of clinical guidelines and audit (...) to optimise patient and service user care. The NCEC has a remit to establish and implement processes for the prioritisation and quality assurance of clinical guidelines and clinical audit so as to recommend them to the Minister for Health to become part of a suite of National Clinical Guidelines and National Clinical Audit. National Clinical Guidelines are “systematically developed statements, based on a thorough evaluation of the evidence, to assist practitioner and service users’ decisions about

2019 National Clinical Guidelines (Ireland)

172. Community-Acquired Pneumonia (CAP) in Adults

outcomes; furthermore, outpatient treatment included daily nursing visits and parenteral antibiotic therapy that is typically restricted to inpatient care. Rationale for the recommendation Our recommendation to use the PSI as an adjunct to clinical judgment to guide the initial site of treatment is based on consistent evidence of the effectiveness and safety of this approach. Using a safe and effective decision aid to increase outpatient treatment of patients with CAP has potential to decrease (...) to MRSA or P. aeruginosa ( see Recommendation 11) are uncommonly managed in the outpatient setting, these patients may require antibiotics that include coverage for these pathogens. Research needed in this area There is a need for head-to-head prospective RCTs of outpatient CAP treatment, comparing clinical outcomes, including treatment failure, need for subsequent visits, hospitalization, time to return to usual activities and adverse events. Furthermore, the prevalence of specific pathogens

2019 Infectious Diseases Society of America

173. Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory

or by palliative care specialists may be FIGURE 1 Clinical Course of Heart Failure Improving towards target Improving towards target Not improved/ worsening Stalled Focus of Care Transition to Oral Therapies Admission Discharge First Follow-up Visit Clinical decompensation Discharge coordination Ongoing optimization of outpatient care Guideline-directed medical therapy Evaluation for long-term trajectory Early acute phase Late acute phase Optimization phase Early post- discharge phase Transition to chronic (...) Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory EXPERT CONSENSUS DECISION PATHWAY 2019 ACC Expert Consensus Decision PathwayonRiskAssessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee Writing Committee Steven M. Hollenberg, MD, FACC, Chair Lynne Warner Stevenson, MD, FACC, Vice Chair Tariq Ahmad, MD, MPH, FACC Vaibhav J. Amin, MD

2019 American College of Cardiology

174. Recommendations for Prevention and Control of Influenza in Children, 2019–2020

of outpatient clinic and emergency department visits for influenzalike illness, high influenza-related hospitalization rates, and high numbers of deaths. – Influenza A(H3N2) viruses predominated through February 2018; influenza B viruses predominated from March 2018 onward. Although hospitalization rates for children that season did not exceed those reported during the 2009 pandemic, they did surpass rates reported in previous high-severity A(H3N2)-predominant seasons. Excluding the 2009 pandemic, the 186 (...) season, replacing the LAIV3. The most commonly reported reactions in children are runny nose or nasal congestion, headache, decreased activity or lethargy, and sore throat. The safety of LAIV in people with a history of asthma, diabetes mellitus, or other high-risk medical conditions associated with an elevated risk of complications from influenza (see Contraindications and Precautions) has not been firmly established. In postlicensure surveillance of LAIV (including LAIV3 and LAIV4), the Vaccine

2019 American Academy of Pediatrics

175. What is the evidence on availability and integration of refugee and migrant health data in health information systems in the WHO European Region?

, was established at the WHO Regional Office for Europe in 2011 to support Member States to strengthen the health sector’s capacity to provide evidence-informed responses to the public health challenges for refugee and migrant health. The programme operates under the umbrella of the European health policy framework Health 2020 and provides support to Member States under four pillars: technical assistance; health information, research and training; policy development; and advocacy and communication (...) systems for the general population because this is also likely to improve the availability of data on refugee and migrant health; • integrate key data elements related to refugees and migrants (e.g. country of birth, nationality, length of stay, reason for migration) into existing data collection systems to facilitate stratified data analysis, identify at-risk subgroups and ensure cross-border comparability; • establish and/or strengthen a tailored, proactive approach to data collection for refugees

2019 WHO Health Evidence Network

176. What are the roles of intercultural mediators in health care and what is the evidence on their contributions and effectiveness in improving accessibility and quality of care for refugees and migrants in the WHO European Region?

and Health programme, formerly known as Public Health Aspects of Migrants in Europe (PHAME), was established in 2011 to support Member States of the WHO European Region to strengthen the health sector’s capacity to provide evidence-informed responses to the public health challenges of refugee and migrant health. The programme operates under the umbrella of the European health policy framework Health 2020. The programme provides support to Member States under four pillars: technical assistance; health (...) providers were found to be lacking. Policy considerations Based on the review findings, the following policy considerations to improve the equity of health services for refugees and migrants can be considered by Member States: • establish clear and coherent definitions of the roles and responsibilities of intercultural mediators working in the health sector; • establish professional guidelines, standards and quality assurance processes to support the recognition and full professionalization

2019 WHO Health Evidence Network

177. BTS/SIGN British Guideline on the Management of Asthma

establish whether or not the airflow obstruction reverses to normal with treatment. Evidence of a symptomatic response, ideally using objective measures of asthma control and lung function, should be sought at a follow-up visit. If there is significant reversibility or improvement in symptom scores, confirm the diagnosis of asthma and record the basis on which the diagnosis was made. Continue to treat as asthma, but aim to find the minimum effective dose of therapy. If the patient remains asymptomatic (...) development group 152 17.3 Acknowledgements 154 17.4 Consultation and peer review 154 Abbreviations 156 Annexes 158 References 1721 1 | Introduction 1 Introduction 1.1 The need for a guideline Asthma is a common condition which produces a significant workload for general practice, hospital outpatient clinics and inpatient services. It is clear that much of this morbidity relates to poor management, particularly around the use of preventative medicine. 1.1.1 Background In 1999 the British Thoracic Society

2019 British Thoracic Society

178. Multiplex polymerase chain reaction gastrointestinal pathogen panels for people with suspected gastroenteritis

of infectious intestinal disease. Clin Infect Dis. 2012;54(9):1275-86. 11. 11. Woodward DL, Clark CG, Caldeira RA, Ahmed R, Rodgers FG. Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada. Can J Infect Dis. 2002;13(5):321-30. 12. 12. Locking ME, Pollock KG, Allison LJ, Rae L, Hanson MF, Cowden JM. Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008. Emerg Infect Dis. 2011;17(3):524-7. 13. 13. Farthing M, Salam MA, Lindberg G, Dite P, Khalif I, Salazar-Lindo E (...) of the infection. The majority of cases resolve within several days without the need for treatment 2 . As such, most cases are self-managed in the community. If severe or persistent symptoms occur, patients may require admission to hospital for observation and symptom management. SHTG Evidence Synthesis | 6 In a minority of cases, infectious pathogens can cause complications which lead to chronic illness or mortality. Infectious gastroenteritis caused by toxin-producing pathogens, such as Verotoxigenic E. coli

2019 SHTG Advice Statements

179. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

( ). A randomized trial compared the safety of inpatient versus outpatient treatment of 49 patients with CURB-65 scores of less than 2 ( ) but had limited power to detect differences in patient outcomes; furthermore, outpatient treatment included daily nursing visits and parenteral antibiotic therapy that is typically restricted to inpatient care. Rationale for the recommendation Our recommendation to use the PSI as an adjunct to clinical judgment to guide the initial site of treatment is based on consistent (...) failure, need for subsequent visits, hospitalization, time to return to usual activities and adverse events. Furthermore, the prevalence of specific pathogens and their antimicrobial susceptibility patterns in outpatients with pneumonia should be monitored. Newer agents, including lefamulin and omadacycline, need further validation in the outpatient setting. Question 9: In the Inpatient Setting, Which Antibiotic Regimens Are Recommended for Empiric Treatment of CAP in Adults without Risk Factors

2019 American Thoracic Society

180. Neratinib (Nerlynx) - Breast cancer, breast neoplasms

. Neratinib was tolerated in rats for up to 6 months with a NOAEL of 10 mg/kg/day. In dogs, neratinib was tolerated for up to 9 months, and although findings related to faecal disturbance were found the NOAEL for dogs is suggested as 6 mg/kg/day. During examination of covalent binding to human serum albumin, neratinib was shown to bind through a, ß unsaturated amide binding to the e amino group of Lysine190 via a protein-enhanced Michael addition. This binding was species dependent and occurred in human (...) , no effects were detected in oestrous cycling or on mating and embryo survival. The NOAEL was determined to be 12 mg/kg/day. Based on exposure established in the rat 26 week general toxicity study, where a NOAEL of 10 mg/kg/day gave a safety margin of 29-fold based on exposure, the fertility NOAEL provides for a sufficient margin for expected human doses (>29-fold). A statement has been proposed to section 4.6 of the SmPC to reflect that no significant changes in fertility parameters in male and female

2018 European Medicines Agency - EPARs

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>